Global Neonatal Jaundice Management Market, By Management (Diagnosis, Treatment), Type (Primary Care, Secondary Care), Technology (Light-Emitting Diode Light Sources, Fluorescent, Halogen, Fiberoptic), End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Users, Others), Distribution Channel (Direct Tender, Retail Sales, Third Party Distribution) – Industry Trends and Forecast to 2031.
Neonatal Jaundice Management Market Analysis and Size
The rising patient population suffering from neonatal jaundice and the increase in awareness about neonatal jaundice are the major drivers that propelled the demand of the market in the forecast period. High technological advancements in diagnosis and treatment are expected to provide various other opportunities in the neonatal jaundice management market. However, product recalls and side-effects related to phototherapy are expected to restraint the market growth in the forecast period.
Data Bridge Market Research analyzes that the global neonatal jaundice management market which was USD 399.11 million in 2023, is likely to reach USD 669.17 million by 2031, and is expected to undergo a CAGR of 26.3% during the forecast period. “Diagnosis” dominates the management segment of the market due to the rising diagnosis rate of neonatal jaundice. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Neonatal Jaundice Management Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2017-2022)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Management (Diagnosis, Treatment), Type (Primary Care, Secondary Care), Technology (Light-Emitting Diode Light Sources, Fluorescent, Halogen, Fiberoptic), End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Users, Others), Distribution Channel (Direct Tender, Retail Sales, Third Party Distribution)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, Saudi Arabia, South Africa, U.A.E., Israel, Egypt and Rest of Middle East and Africa
|
|
Market Players Covered
|
Atom Medical Corp. (Japan), avihealthcare (India), Natus Medical Incorporated. (U.S.), DAVID (Germany), Signify Holding. (Netherlands), Weyer GmbH (Germany), nice Neotech Medical Systems Pvt. Ltd. (India), Phoenix Medical Systems (P) Ltd (India), Aeroflow, Inc. (U.S.), Zhengzhou Dison Instrument And Meter Co., Ltd (China), GENERAL ELECTRIC COMPANY (U.S.), Neolight (U.S.), Ardo (Switzerland), NeoMedLight (U.K.), S S TECHNOMED(P)LTD (India), Drägerwerk AG & Co. KGaA (Germany), Braun & Co. Limited (Germany), HERBERT WALDMANN GMBH & CO. KG (Germany), GINEVRI srl (Italy), Shvabe Zurich GmbH (Switzerland)
|
|
Market Opportunities
|
|
Market Definition
Neonatal jaundice management involves a comprehensive approach to diagnosing, monitoring, and treating jaundice in newborns, a condition marked by yellow discoloration due to elevated bilirubin levels. This encompasses diagnostic tools, including transcutaneous bilirubinometry and serum bilirubin testing, alongside phototherapy devices such as lamps or blankets emitting blue light for bilirubin conversion. Monitoring devices track treatment effectiveness, and in severe cases, advanced treatments like exchange transfusion may be used. Supportive care and caregiver education play pivotal roles.
Global Neonatal Jaundice Management Market Dynamics
Drivers
- High Incidence of Neonatal Jaundice
The market is driven by the high incidence of neonatal jaundice worldwide. This condition is common in newborns due to factors such as the immaturity of the liver, which takes time to efficiently process bilirubin. As birth rates remain substantial globally, the demand for effective jaundice management solutions, including diagnostic tools and treatment modalities, continues to rise.
- Technological Advancements in Diagnostic and Treatment Solutions
Ongoing technological advancements contribute significantly to the growth of the market. Innovations in diagnostic tools, such as non-invasive transcutaneous bilirubinometry, and improvements in phototherapy devices enhance the accuracy and efficiency of jaundice management. These advancements attract healthcare providers and contribute to the overall market expansion.
- Growing Awareness and Healthcare Infrastructure
Increasing awareness among healthcare professionals and caregivers regarding the importance of early detection and management of neonatal jaundice is a key driver. Improved healthcare infrastructure, particularly in developing regions, facilitates timely diagnosis and treatment. Efforts in educating parents and caregivers about neonatal jaundice, its signs, and the significance of seeking prompt medical attention contribute to the market's growth.
- Growing Investment for Healthcare Facilities
Surging focus towards improving the condition of healthcare facilities and improving the overall healthcare infrastructure another important factor fostering the growth of the market. Rising number of partnerships and strategic collaborations between the public and private players pertaining to funding and application of new and improved technology is further creating lucrative market opportunities.
Opportunities
- Increasing Focus on Preventive Healthcare
The market has the opportunity to capitalize on the growing emphasis on preventive healthcare. Education campaigns for expectant parents and healthcare professionals can raise awareness about the importance of early detection and management of neonatal jaundice. This focus on prevention creates opportunities for the development and adoption of cost-effective and accessible screening tools, contributing to the expansion of the market.
- Rising Investments in Healthcare Infrastructure
The increasing investments in healthcare infrastructure, especially in developing regions, present opportunities for the neonatal jaundice management market. Improved healthcare facilities and expanded access to medical services create a conducive environment for the adoption of advanced diagnostic tools and treatment options. This trend is particularly noteworthy as healthcare systems evolve to meet the demands of growing populations.
Restraints
- High Cost of Advanced Treatment Modalities
While advanced treatment modalities, such as exchange transfusion, can be highly effective in severe cases of neonatal jaundice, their high cost presents a restraint. Affordability issues, particularly in regions with limited healthcare resources, can limit the widespread adoption of these advanced treatments, affecting overall market expansion.
- Risk of Adverse Effects from Intensive Treatments
Some advanced treatment options for neonatal jaundice, such as exchange transfusion, carry inherent risks of adverse effects. The potential complications associated with intensive treatments may lead to concerns among healthcare providers and parents, impacting the acceptance and utilization of these interventions. Balancing the benefits and risks of such treatments poses a challenge, influencing the overall dynamics of the neonatal jaundice management market.
Challenges
- Limited Awareness and Education in Some Regions
In certain regions, there may be a lack of awareness and education about neonatal jaundice among healthcare providers, parents, and caregivers. Limited understanding of the condition and its potential complications can result in delayed diagnosis and treatment. Overcoming this challenge requires targeted educational campaigns and training programs to enhance awareness and knowledge about neonatal jaundice management.
- Resource constraints in low-income settings
Resource constraints, including financial limitations and inadequate healthcare infrastructure, pose significant challenges for the market. In low-income settings, there may be limited access to advanced diagnostic tools and treatment options, hindering effective management. Addressing this challenge involves developing cost-effective solutions and establishing initiatives to improve healthcare infrastructure in resource-limited areas.
This neonatal jaundice management market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the neonatal jaundice management market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In June 2022, Frost & Sullivan selected Dräger for its 2022 Global New Product Innovation Leadership Award in the categories of neonatal and respiratory care
- In May 2022, Pinnacle Industries, an automotive seating, interiors, and specialty vehicles company, launched the newest range of approved neonatal ambulances specially developed for the Maharashtra Government, India. These Ambulances are equipped with all necessary medical facilities and advanced technologies to deliver the best medical care to newborns
Global Neonatal Jaundice Management Market Scope
The neonatal jaundice management market is segmented on the basis of management, type, technology, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Management
- Treatment
- Diagnosis
Type
- Primary care
- Secondary care
Technology
- Fluorescent
- Halogen
- Fiberoptic
- Light-emitting diode light sources
- Others
End user
- Hospitals
- Clinics
- Ambulatory surgical centers
- Home users
- Others
Distribution channel
- Direct tender
- Retail sales
- Third party distribution
Global Neonatal Jaundice Management Market Regional Analysis/Insights
The neonatal jaundice management market is analyzed and market size insights and trends are provided by country, management, type, technology, end user and distribution channel as referenced above.
The countries covered in the market report are U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, Saudi Arabia, South Africa, U.A.E., Israel, Egypt, and rest of Middle East and Africa.
North America is expected to dominate the market due to the rise in the demand for telemedicine. Furthermore, the growing of the healthcare understanding combined with cloud-based technologies acknowledgment which will further boost the growth of the market in the region during forecast period.
Asia-Pacific is expected to observe significant amount of growth in the market due to the rapid necessity for telemedicine and healthcare support. Moreover, the modernization and development in telecommunication is further anticipated to propel the growth of the neonatal jaundice management market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The neonatal jaundice management market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for neonatal jaundice management market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the neonatal jaundice management market. The data is available for historic period 2010-2020.
Competitive Landscape and Global Neonatal Jaundice Management Market Share Analysis
The neonatal jaundice management market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the neonatal jaundice management market.
Some of the major players operating in the neonatal jaundice management market are:
- Atom Medical Corp. (Japan)
- avihealthcare (India)
- Natus Medical Incorporated. (U.S.)
- DAVID (Germany)
- Signify Holding. (Netherlands)
- Weyer GmbH (Germany)
- Neotech Medical Systems Pvt. Ltd. (India)
- Phoenix Medical Systems (P) Ltd (India)
- Aeroflow, Inc. (U.S.)
- Zhengzhou Dison Instrument and Meter Co., Ltd (China)
- GENERAL ELECTRIC COMPANY (U.S.)
- Neolight (U.S.)
- Ardo (Switzerland)
- NeoMedLight (U.K.)
- S S TECHNOMED(P)LTD (India)
- Drägerwerk AG & Co. KGaA (Germany)
- Braun & Co. Limited (Germany)
- HERBERT WALDMANN GMBH & CO. KG (Germany)
- GINEVRI srl (Italy)
- Shvabe Zurich GmbH (Switzerland)
SKU-